BioSpace News Archive

Jnana Therapeutics announced that Joanne Kotz, Ph.D., Co-founder and Chief Executive Officer, will present a corporate overview at the Jefferies Healthcare Conference on Friday, June 9, 2023 at 10:00 a.m. ET.

IGM Biosciences, Inc., a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, announced that Fred Schwarzer, Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference on Thursday, June 8, 2023, at 1:30 p.m. EDT in New York.

Tango Therapeutics, Inc. announced that members of the management team are scheduled to participate in the following upcoming investor conferences in June.

Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that enrollment has opened in ODYSSEY, its Phase 2b clinical trial of CLS-AX (axitinib injectable suspension) using suprachoroidal delivery in neovascular age-related macular degeneration (wet AMD).

Axsome Therapeutics, Inc. announced presentations on Sunosi® at SLEEP 2023, the annual meeting of the American Academy of Sleep Medicine and the Sleep Research Society, being held in Indianapolis, Ind., from June 3-7, 2023.

atai Life Sciences will participate in upcoming June Investor Conferences. Details of the company’s participation are as follows.

Karyopharm Therapeutics Inc. today announced that the Company’s senior management team will participate at the Jefferies Healthcare Conference in a fireside chat on Thursday, June 8, 2023 at 10:00 a.m. ET in New York, NY.

Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that Vish Seshadri, Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference on Friday, June 9, 2023 at 9:00 a.m. Eastern time.

Landmark Bio and InnDura Therapeutics have announced a new collaboration to develop and execute product development, regulatory, and chemistry, manufacturing and control (CMC) strategies to progress InnDura’s lead program to the clinic.

Oculis Holding AG announces that Riad Sherif, MD, Chief Executive Officer, and Sylvia Cheung, Chief Financial Officer, will attend the 2023 Jefferies Global Healthcare Conference in New York, from Wednesday, June 7 to Friday, June 9 for 1:1 meetings and will deliver a corporate presentation, on Friday, June 9, 2023 at 11:00-11:25 AM Eastern Time in Track 8.